Hyperbaric Oxygen Therapy for Malignancy: A Review
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
One unique feature of tumors is the presence of hypoxic regions, which occur predominantly at the tumor center. Hypoxia has a major impact on various aspects of tumor cell function and proliferation. Hypoxic tumor cells are relatively insensitive to conventional therapy owing to cellular adaptations effected by the hypoxic microenvironment. Recent efforts have aimed to alter the hypoxic state and to reverse these adaptations to improve treatment outcome. One way to increase tumor oxygen tensions is by hyperbaric oxygen (HBO) therapy. HBO therapy can influence the tumor microenvironment at several levels. It can alter tumor hypoxia, a potent stimulus that drives angiogenesis. Hyperoxia as a result of HBO also produces reactive oxygen species, which can damage tumors by inducing excessive oxidative stress. This review outlines the importance of oxygen to tumors and the mechanisms by which tumors survive under hypoxic conditions. It also presents data from both experimental and clinical studies for the effect of HBO on malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · cited 2×
“Similarly, loss of HIF-1a in endothelial cells results in profound inhibition of blood vessel growth in solid tumors(54) and causes vascular regression in HIF-1a-deficient mouse embryos.(52) This shows that HIF-1 is a key transcriptional mediator of VEGF-induced angiogenesis in response to hypoxia(55,56) (Fig.”
BackgroundHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · cited 4×
“Hypoxic regions have also been correlated with reduced apoptotic potential of tumors with a highly malignant phenotype.(23,68) The cellular responses described above are adaptations tumor cells make as a result of oxygen deficiency.”
BackgroundInfluentialGray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Persistent oxidative stress in cancer
Toyokuni, S., Okamoto, K., Yodoi, J., & Hiai, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01368-b · Cited by 1,219
Choi, A. M., & Alam, J. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.15.1.8679227 · Cited by 1,126
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967 · cited 3×
“Hypoxia also disrupts the regulation of other genes associated with apoptosis.(68,80) Members of the Bcl-2 family act as inhibitors (Bcl-2, Bcl-XI, Bcl-W) and promoters (Bax, Bad, Bak, Bcl-Xs) of apoptosis.”
BackgroundGlutathione Peroxidase: The Primary Agent for the Elimination of Hydrogen Peroxide in Erythrocytes*
Cohen, G., & Hochstein, P. (1963) · Biochemistry · doi:10.1021/bi00906a038 · Cited by 666 · cited 1×
“Chronic exposure of cells to high glucose levels has been shown to increase intracellular reactive oxygen species (ROS) production.(94) Due to the low ATP yield from glycolysis, ATP is generated from alternate sources such as the degradation of cellular proteins and amino acids.”
BackgroundROS, stress‐activated kinases and stress signaling in cancer
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf094 · Cited by 600 · cited 3×
“Low levels of ROS are generated in the mitochondria and are important for regulating signal transduction and normal cell proliferation and function.(98,99) ROS include the superoxide anion (O2 ), hydroxyl radical (OH), hydrogen peroxide (H2O2), and singlet oxygen ( (1)O2).”
BackgroundTumor hypoxia and malignant progression
Vaupel, P., Mayer, A., & Höckel, M. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)81023-1 · Cited by 496
Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1
Arnold, R. S., Shi, J., Murad, E., Whalen, A. M., Sun, C. Q., Polavarapu, R., Parthasarathy, S., Petros, J. A., & Lambeth, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101505898 · Cited by 486 · cited 1×
“These mutations may affect the genes responsible for apoptosis or induce oncogenic transformation of cells.(108,109) ROS promote the constant activation of transcription factors, leading to increased proliferation of cells with acquired DNA damage.”
BackgroundRADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCER
Henk, J. M., & Smith, C. W. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90117-9 · Cited by 320
RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCER
Henk, J. M., Kunkler, P. B., & Smith, C. W. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90116-7 · Cited by 229 · cited 1×
“However, better local tumor control was observed in the HBO group with minimal salvage surgery compared to the non-HBO group.(11) In most of the cases, however, HBO has provided no added benefit during radiotherapy especially in the treatment of patients with cervical cancer.”
ResultHyperbaric oxygen: the Medical Research Council trials and their clinical significance
Dische, S. (1978) · The British Journal of Radiology · doi:10.1259/0007-1285-51-611-888 · Cited by 154 · cited 2×
“In another randomized control trial conducted in that same year, HBO therapy gave no additional therapeutic benefit and in fact increased the occurrence of late morbidity.(152) This may be due to the combined HBO group being given more fractions of radiation compared to the control group, where patients received stand…”
BackgroundResultImprovement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶
Chen, Q., Huang, Z., Chen, H., Shapiro, H., Beckers, J., & Hetzel, F. W. (2007) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2002)0760197iotrbm2.0.co2 · Cited by 124
Maier, A., Tomaselli, F., Anegg, U., Rehak, P., Fell, B., Luznik, S., Pinter, H., & Smolle-Jüttner, F. M. (2000) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(00)00592-3 · Cited by 54
KONDO, Y., HAMADA, J., KOBAYASHI, C., NAKAMURA, R., SUZUKI, Y., KIMATA, R., NISHIMURA, T., KITAGAWA, T., KUNIMOTO, M., IMURA, N., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000154343.35444.09 · Cited by 26
Cited by
Chen, J., Luo, H., Liu, Y., Zhang, W., Li, H., Luo, T., Zhang, K., Zhao, Y., & Liu, J. (2017) · ACS Nano · doi:10.1021/acsnano.7b08225 · Cited by 451
Hypoxia, inflammation, and the tumor microenvironment in metastatic disease
Finger, E. C., & Giaccia, A. J. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9224-5 · Cited by 370
Photodynamic nanomedicine in the treatment of solid tumors: Perspectives and challenges
Master, A., Livingston, M., & Sen Gupta, A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.02.020 · Cited by 367
'Go or Grow': the key to the emergence of invasion in tumour progression?
Hatzikirou, H., Basanta, D., Simon, M., Schaller, K., & Deutsch, A. (2012) · Mathematical Medicine and Biology · doi:10.1093/imammb/dqq011 · Cited by 363
Hyperbaric oxygen therapy and cancer—a review
Moen, I., & Stuhr, L. E. B. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0233-x · Cited by 298
Metadata
- Authors
- Daruwalla, J., & Christophi, C.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2006-11-07
- Volume
- 30
- Issue
- 12
- Pages
- 2112-31
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W2066694851
- Cited by
- 129
- References
- 23
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.